Brainsway Ltd. BRSYF

BRSYF Company Overview

BrainsWay Ltd. is an Israel-based medical device company focused on noninvasive neurostimulation therapies for mental health and neurological disorders. The company develops and commercializes transcranial magnetic stimulation (TMS) systems using its proprietary Deep TMS technology, which is designed to stimulate broader and deeper regions of the brain than conventional TMS systems. BrainsWay operates primarily within the medical technology, psychiatry, neurology, and digital health sectors, with revenue driven mainly through sales and leasing of Deep TMS systems, treatment coils, service agreements, and recurring disposable components used by healthcare providers.

The company’s principal customer base includes psychiatric clinics, hospitals, academic medical centers, and specialty mental health practices. BrainsWay’s systems have received regulatory clearances for multiple indications, including major depressive disorder, obsessive-compulsive disorder, smoking addiction, and anxious depression in certain jurisdictions. The company originated from research conducted at the National Institute for Psychobiology in Israel and was formally established in 2003. Over time, it evolved from a research-stage neurotechnology developer into a commercial-stage medical device company with regulatory approvals in North America, Europe, and other international markets. Its strategic positioning centers on clinically validated Deep TMS technology, an expanding intellectual property portfolio, and a growing installed base in psychiatric care settings.